| Title | Author(s) | Issue date | ???itemlist.??? |
| Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia | Tsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M. S. | 24-Nov-2015 | - |
| Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia | Tsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M. | 24-Nov-2015 | - |
| Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity | Tselepis, A. D.; Elisaf, M.; Besis, S.; Karabina, S. A. P.; Chapman, M. J.; Siamopoulou, A. | 24-Nov-2015 | - |
| Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity | Tselepis, A. D.; Elisaf, M. S.; Besis, S.; Karabina, S. A.; Chapman, M. J.; Siamopoulou, A. | 24-Nov-2015 | - |
| Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB | Tsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
| Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB | Tsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M. S.; Tselepis, A. D. | 24-Nov-2015 | - |
| Chondroitin sulfate glycosaminoglycans are essential for the cellular assembly and secretion of PAF-acetylhydrolase by human adherent monocytes | Tselepis, A. D.; Karabina, S. A.; Stengel, D.; Piedagnel, R.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies: Protective role of PAF: acetylhydrolase in dense LDL | Tsoukatos, D. C.; Arborati, M.; Liapikos, T.; Clay, K. L.; Murphy, R. C.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins | Tsimihodimos, V.; Kakafika, A.; Tambaki, A. P.; Bairaktari, E.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D. | 24-Nov-2015 | - |
| Formation of platelet-activating factor and its bioactive analogues upon Cu2+ induced LDL oxidation | Tsoukatos, D. C.; Androulakis, N.; Tselepis, A. D.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase | Tselepis, A. D.; Chapman, M. J. | 24-Nov-2015 | - |
| The inflammatory state in active juvenile rheumatoid arthritis is associated with hypo HDL-EMIA and reduced lipoprotein-associated PAF-acetylhydrolase activity | Tselepis, A. D.; Elisaf, M. S.; Besis, S.; Karabina, S. A. P.; Chapman, M. J.; Siamopoulou, A. | 24-Nov-2015 | - |
| Mechanisms of PAF formation upon copper-catalyzed oxidation of human LDL | Tsoukatos, D. C.; Liapikos, T. A.; Tselepis, A. D.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL | Tselepis, A. D.; Karabina, S. A. P.; Stengel, D.; Piedagnel, R.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| PAF-acetylhydrolase is an antiinflammatory and antioxidant phospholipase A(2) that may be implicated in atherothrombosis | Tselepis, A. D.; Elisaf, M. S.; Goudevenos, J.; Karabina, S. A.; Tsoukatos, D.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Paf-Degrading Acetylhydrolase Is Preferentially Associated with Dense Ldl and Vhdl-1 in Human Plasma - Catalytic Characteristics and Relation to the Monocyte-Derived Enzyme | Tselepis, A. D.; Dentan, C.; Karabina, S. A. P.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase | Dentan, C.; Tselepis, A. D.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein | Tsoukatos, D. C.; Liapikos, T. A.; Tselepis, A. D.; Chapman, M. J.; Ninio, E. | 24-Nov-2015 | - |
| Reduced HDL levels are a major feature of the dyslipidemia characteristic of juvenile chronic arthritis | Tselepis, A. D.; Besis, S.; Elisaf, M.; Karabina, S. A. P.; Lapatsanis, P. D.; Chapman, M. J.; Siamopoulou, A. | 24-Nov-2015 | - |
